The REDUCE LAP-HF IV study is evaluating the Corvia® Atrial Shunt to improve quality of life and reduce HF-related symptoms and hospitalizations in people with HF with elevated left atrial pressure.
If you are 40 years or older, have symptoms of heart failure, and meet additional study criteria, you may be eligible to participate. Prior to participation, your doctor will review all relevant study information with you. The potential benefits and risks will also be discussed in detail to help you decide whether the study may be right for you. Read more about the REDUCE LAP-HF IV study at www.clinicaltrials.gov.